Latest Insider Transactions at Insmed Inc (INSM)
This section provides a real-time view of insider transactions for Insmed Inc (INSM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INSMED Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INSMED Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 04
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Bona fide gift
|
Direct |
23,303
-29.21%
|
-
|
|
Sep 02
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
24,272
-5.82%
|
$3,470,896
$143.6 P/Share
|
|
Sep 02
2025
|
Michael Alexander Smith Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,780
+13.9%
|
$383,400
$30.46 P/Share
|
|
Sep 02
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
186,648
-16.96%
|
$26,690,664
$143.65 P/Share
|
|
Sep 02
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
186,648
+11.74%
|
$4,479,552
$24.71 P/Share
|
|
Aug 20
2025
|
Melvin Md Sharoky Director |
SELL
Open market or private sale
|
Direct |
10,000
-3.51%
|
$1,290,000
$129.5 P/Share
|
|
Aug 19
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
25,000
-9.9%
|
$3,175,000
$127.85 P/Share
|
|
Aug 18
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,865
-0.96%
|
$878,720
$128.61 P/Share
|
|
Aug 18
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,865
+2.77%
|
$68,650
$10.85 P/Share
|
|
Aug 14
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.83%
|
$1,270,000
$127.48 P/Share
|
|
Aug 13
2025
|
Melvin Md Sharoky Director |
BUY
Bona fide gift
|
Indirect |
5,000
+42.2%
|
-
|
|
Aug 13
2025
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Indirect |
15,000
-94.34%
|
-
|
|
Aug 13
2025
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
6,100
-2.1%
|
-
|
|
Aug 12
2025
|
Melvin Md Sharoky Director |
SELL
Open market or private sale
|
Direct |
10,000
-3.33%
|
$1,210,000
$121.58 P/Share
|
|
Aug 04
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$744,470
$109.8 P/Share
|
|
Aug 04
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Aug 04
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,715
-9.49%
|
$949,935
$109.5 P/Share
|
|
Aug 04
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,715
+8.67%
|
$165,585
$19.74 P/Share
|
|
Jul 21
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
58,400
-25.34%
|
$5,956,800
$102.7 P/Share
|
|
Jul 21
2025
|
Sara Bonstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,888
+9.45%
|
$1,388,752
$29.62 P/Share
|
|
Jul 15
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
933
-1.39%
|
$95,166
$102.51 P/Share
|
|
Jul 15
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$696,660
$102.56 P/Share
|
|
Jul 15
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Jul 11
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
748
-1.1%
|
$71,808
$96.41 P/Share
|
|
Jul 07
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
57,764
-22.99%
|
$5,487,580
$95.93 P/Share
|
|
Jul 07
2025
|
Sara Bonstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,888
+8.56%
|
$1,149,312
$24.33 P/Share
|
|
Jul 01
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$669,340
$98.72 P/Share
|
|
Jul 01
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Jun 23
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
57,765
-20.46%
|
$5,834,265
$101.93 P/Share
|
|
Jun 23
2025
|
Sara Bonstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,889
+13.99%
|
$909,891
$19.35 P/Share
|
|
Jun 16
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,686
-3.85%
|
$1,047,228
$98.91 P/Share
|
|
Jun 16
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
129,805
-10.29%
|
$12,850,695
$99.95 P/Share
|
|
Jun 16
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
129,805
+26.3%
|
$1,298,050
$10.85 P/Share
|
|
Jun 16
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
5,204
-0.42%
|
$520,400
$100.06 P/Share
|
|
Jun 11
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
99,172
-13.36%
|
$9,222,996
$93.88 P/Share
|
|
Jun 11
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,000
+27.07%
|
$910,000
$13.91 P/Share
|
|
Jun 11
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19,423
-18.94%
|
$1,825,762
$94.5 P/Share
|
|
Jun 11
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,423
+15.93%
|
$330,191
$17.07 P/Share
|
|
Jun 10
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
38,300
-24.41%
|
$3,370,400
$88.64 P/Share
|
|
Jun 10
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,300
+19.62%
|
$651,100
$17.16 P/Share
|
|
Jun 10
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,740
-23.65%
|
$2,265,120
$88.64 P/Share
|
|
Jun 10
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,740
+19.12%
|
$669,240
$26.46 P/Share
|
|
Jun 10
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
57,766
-7.0%
|
$5,141,174
$89.47 P/Share
|
|
Jun 10
2025
|
Sara Bonstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,890
+13.89%
|
$862,020
$18.01 P/Share
|
|
Jun 05
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,879
-2.7%
|
$137,167
$73.5 P/Share
|
|
Jun 04
2025
|
David W J Mcgirr Director |
SELL
Open market or private sale
|
Direct |
3,000
-2.98%
|
$219,000
$73.27 P/Share
|
|
Jun 03
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,579
-1.37%
|
$112,109
$71.5 P/Share
|
|
Jun 03
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,860
-1.3%
|
$132,060
$71.5 P/Share
|
|
Jun 03
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,686
-1.99%
|
$119,706
$71.5 P/Share
|
|
Jun 03
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,448
-2.04%
|
$102,808
$71.5 P/Share
|